what biotech has to offer

Pharmaceutical company Bayer has developed a non-hormonal drug, called Elinzanetant, that could alleviate symptoms like hot flashes, commonly associated with menopause. Currently pending FDA approval, phase 3 trials showed it not only reduced the frequency and severity of hot flashes, but it also improved sleep disturbances and overall quality of life, compared to a placebo. This drug would compete with the similar, FDA-approved Veozah, which was hailed as “game-changing” in the treatment of menopausal symptoms.